Philippine Health Research Registry
Display Options
Results List
Results 1 - 6 of 6 research(es) registered in October 2018

Show: All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#
Study
         
Project Status:
Ongoing
Project Description:
This study aims to determine the extent of fraud in payments made by PhilHealth for benefit claims and to map out areas in PhilHealth claims processing system where fraud is highly susceptible to be committed.  
Project Status:
Ongoing
Project Description:
Cordillera Administrative Region (CAR) is divided into eight ethnolinguistic groups and each indigenous and local community possesses a unique body of traditional knowledge and practices which had been developed throughout centuries of use and has been passed down to succeeding generations. It includes the peoples’ wealth of knowledge including t... [read more]
Project Status:
Ongoing
Project Description:
The HATID ASEAN Project is a convergence project to provide an opportunity for three ASEAN countries (the Philippines, Thailand and Indonesia) to address cross-cutting issues pertaining to program management and service delivery via existing eHealth technologies. It aims to strengthen selected components of health management programs and health se... [read more]
Project Status:
Pending
Project Description:
This is the first study in the Philippines to evaluate both chronic and acute maternal and fetal cardiovascular responses to Shen Zhen Gong exercise using multi-modal fetal surveillance techniques which include 2D-ultrasonography, Color Doppler studies, cardiotocography and non-invasive (maternal and fetal) electrocardiography. The study will provi... [read more]
Project Status:
Ongoing
Project Description:
The study is a prospective, multinational, multicenter observational registry utilizing a cloud-based eCRF that aims to provide real world data on patient characteristics, disease management, healthcare utilization and outcomes in patients with type 2 diabetes
Project Status:
Pending
Project Description:
This is a Phase III, double-blind, randomized, multicenter study to compare the efficacy and to evaluate the safety and immunogenicity of TX05 (trastuzumab) with Herceptin® in subjects with HER2 positive early breast cancer.